Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
623 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitair Ziekenhuis Antwerpen
Edegem, Belgium
- Institut Bergonie Cancer Center
Bordeaux, France
- Centre Georges-Francois Leclerc
Dijon, France
- Centre Leon Berard
Lyon, France
- Centre Catherine de Sienne
Nantes, France
- University Medical Center Groningen
Groningen, Netherlands
- University of Oslo
Oslo, Norway
- Hospital Clinico San Carlos
Madrid, Spain
- Addenbrookes Hospital-Medical School
Cambridge, England, United Kingdom
- University College London Hospital
London, England, United Kingdom
- Christie Hospital
Manchester, England, United Kingdom
- Weston Park Hospital
Sheffield, England, United Kingdom
- Beatson Oncology Center
Glasgow, Scotland, United Kingdom
- Institute of Cancer Research - Chelsea
London, United Kingdom
- Tennessee Valley Gynecologic Oncology
Huntsville, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Sutter Davis Hospital
Davis, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jun 2012
- Primary completion
- 30 Jun 2018
- Completion
- 9 Feb 2019
- Last update posted
- 28 Apr 2020
- Registered enrollment
- 38
- Registry id
- NCT01533207
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.